sur The Vanguard Group, Inc. (isin : US12572Q1058)
Vanguard Discloses Position in Mural Oncology
The Vanguard Group, Inc. has filed Form 8.3 regarding its position in Mural Oncology plc, as per the Irish Takeover Panel rules. As of August 12, 2025, Vanguard holds 771,939 ordinary shares in Mural Oncology, representing 4.47% of relevant securities. This filing follows the requirement for disclosure by entities with interests exceeding 1% in involved securities.
No deals involving options, derivatives, or new securities have been declared. Vanguard performed a sale of 432 ordinary shares at $1.66 each. No additional agreements or dealings impacting securities were reported. The disclosure highlights Vanguard's transparency and compliance with Irish regulations during potential corporate changes involving Mural Oncology.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.